Showing results (771-780 of 936) with videos related to

Sort By:
Pageof 94
Nature Communications|April 22, 2024
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough diseaseRuth E Drury, Susana Camara, Irina Chelysheva, et al.
The Journal of Biological Chemistry|April 5, 2003
O-glycan sialylation and the structure of the stalk-like region of the T cell co-receptor CD8Anthony H Merry, Robert J C Gilbert, David A Shore, et al.
Vaccine|September 6, 2001
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzeesJ Schneider, J A Langermans, S C Gilbert, et al.
International Journal of Obesity (2005)|November 26, 2008
Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional StudyL Béghin, M Castera, Y Manios, et al.
Plos One|July 15, 2026
Likweli: A remarkable new species of Colobus monkey from the Lomami National Park, Democratic Republic of CongoJohn A Hart, Junior D Amboko, Julia L Arenson, et al.
Vaccine|August 4, 2009
Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccinesKaren Colbjørn Larsen, Alexandra J Spencer, Anna L Goodman, et al.
Vaccine|December 1, 2015
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoterNaif Khalaf Alharbi, Alexandra J Spencer, Ahmed M Salman, et al.
Journal of Human Evolution|July 27, 2016
Internal carotid arterial canal size and scaling in Euarchonta: Re-assessing implications for arterial patency and phylogenetic relationships in early fossil primatesDoug M Boyer, E Christopher Kirk, Mary T Silcox, et al.
Plos Clinical Trials|October 21, 2006
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in KenyaPhilip Bejon, Jedidah Mwacharo, Oscar Kai, et al.
Blood|January 10, 2009
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1Robert C Carlisle, Ying Di, Anna M Cerny, et al.
Pageof 94